title: Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital.
abstract: BACKGROUND
  The potential drug-drug interaction (pDDI) increases as the number of concomitant medications increases. Patients with cardiovascular disorders are at higher risk for drug- drug interactions because of the types and number of drugs they receive. While drug interactions are reported to be common, there is no published report of the prevalence of such interactions among Indian cardiac patients. The aim of the present study was to identify the pattern of pDDI and document any observed interaction. It was also planned to evaluate the demography of patients and correlate it with the drug-drug interactions.
  
  
  METHODS
  A prospective observational study from Oct 2007 to Apr 2008 was carried out in 'cardiology department' of a hospital in South India. Those patients who were taking at least two drugs and had a hospital stay of at least 48 hours were included in the study. The medications of the patients were analyzed for possible interactions. Factors associated with pDDI were studied. The actual interactions that were observed during the hospital stay in the study subjects were documented.
  
  
  RESULTS
  A total of 812 patients were included in the study. 388 pDDIs were identified among 249 patients. The incidence of pDDI was 30.67%. The most common potential interactions were between aspirin & heparin (29.38%), and clopidogrel & heparin (7.21%). Drug classes most commonly involved were antiplatelets, anticoagulants and diuretics. Majority of interactions were of moderate severity, delayed onset, and pharmacodynamic in nature. Total 68 actual interactions were observed in the observed cases.
  
  
  CONCLUSIONS
  The present study identified pDDIs and also documented interactions in cardiovascular patients. Factors which had correlation with adverse drug interactions were identified. This study highlights the need for screening prescriptions of cardiovascular patients for pDDIs and proactive monitoring of patients who have identified risk factors; this helps in detection and prevention of possible adverse drug interactions.
authors: Post Graduate Student, Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, India.
authors: Virendra K
authors: VK
authors: Patel
authors: Leelavathi D
authors: LD
authors: Acharya
authors: Thiyagu
authors: T
authors: Rajakannan
authors: Mallayasamy
authors: M
authors: Surulivelrajan
authors: Vasudeva
authors: V
authors: Guddattu
authors: Ramachandran
authors: R
authors: Padmakumar
keywords: Anticoagulants; Antiplatelets; Bleeding; Cardiology; Diuretics; Potential Drug-Drug interactions; Severity
references: Rev Med Interne. 1989 Nov-Dec;10(6):521-5
references: 2488503
references: Pharm Pract (Granada). 2007 Jan;5(1):17-20
references: 25214913
references: Arch Intern Med. 1995 Oct 9;155(18):1949-56
references: 7575048
references: Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):641-51
references: 17154346
references: Best Pract Res Clin Gastroenterol. 2001 Dec;15(6):897-918
references: 11866484
references: Pharmacotherapy. 1998 Sep-Oct;18(5):1112-20
references: 9758323
references: N Engl J Med. 1991 Feb 7;324(6):377-84
references: 1824793
references: Crit Rev Oncol Hematol. 2003 Nov;48(2):133-43
references: 14607376
references: Res Social Adm Pharm. 2007 Dec;3(4):426-37
references: 18082877
references: Am J Health Syst Pharm. 2007 Jul 15;64(14):1500-5
references: 17617500
references: Eur J Intern Med. 2008 Oct;19(6):413-20
references: 18848174
references: Am J Geriatr Cardiol. 2000 May;9(3):127-129
references: 11416550
references: Int J Clin Pharmacol Ther. 2000 Nov;38(11):504-13
references: 11097142
references: Eur J Clin Pharmacol. 1997;53(1):13-7
references: 9349924
references: Drug Saf. 2005;28(3):263-75
references: 15733030
references: Drug Saf. 2006;29(1):79-90
references: 16454536
references: Eur J Clin Pharmacol. 2003 Mar;58(11):773-8
references: 12634985
references: Am J Health Syst Pharm. 1999 Aug 1;56(15):1524-9
references: 10478990
references: Am J Hypertens. 2004 May;17(5 Pt 1):421-7
references: 15110901
references: BMJ. 2004 Jul 3;329(7456):15-9
references: 15231615
references: J Pharm Pharm Sci. 2006;9(3):427-33
references: 17207423
references: Fam Pract. 1991 Sep;8(3):234-6
references: 1822974
references: Pharm World Sci. 1998 Aug;20(4):173-7
references: 9762729
references: J Gerontol Nurs. 2005 Sep;31(9):4-11
references: 16190007
references: Lancet. 1984 Sep 8;2(8402):564-7
references: 6147611